ChemicalBook > CAS DataBase List > ticilimumab tremelimumab
ticilimumab tremelimumab
- Product Name
- ticilimumab tremelimumab
- CAS No.
- 745013-59-6
- Chemical Name
- ticilimumab tremelimumab
- Synonyms
- Ticilimumab;Tremelimumab;ticilimumab tremelimumab;Tremelimumab (anti-CTLA-4);Research Grade Ticilimumab (DHD17204);Research Grade Tremelimumab (DHD17203)
- CBNumber
- CB41518542
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
ticilimumab tremelimumab Property
- storage temp.
- Store at -20°C
More
Less
N-Bromosuccinimide Price
American Custom Chemicals Corporation
- Product number
- ATB0010219
- Product name
- TREMELIMUMAB
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $499.29
- Updated
- 2021/12/16
ticilimumab tremelimumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
ticilimumab tremelimumab Suppliers
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10055
- Advantage
- 58
- Tel
- 010-56205725
- Fax
- 010-65763397
- waley188@sohu.com
- Country
- China
- ProdList
- 12338
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9709
- Advantage
- 58
- Tel
- 17754423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8011
- Advantage
- 62
- Tel
- 027-65279366 18162686757
- biolab-reagents@atagenix.com
- Country
- China
- ProdList
- 9816
- Advantage
- 58
- Tel
- 13720134139 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 5223
- Advantage
- 58
- Tel
- +86-18521732826
- market@aladdin-e.com
- Country
- China
- ProdList
- 48467
- Advantage
- 58
- Tel
- 0731-18670069958 18670069958
- 184792226@qq.com
- Country
- China
- ProdList
- 3007
- Advantage
- 58
- Tel
- 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9623
- Advantage
- 58
- Tel
- +1-833-552-7181
- sales@aladdinsci.com
- Country
- United States
- ProdList
- 57511
- Advantage
- 58
745013-59-6, ticilimumab tremelimumabRelated Search:
Follicle stimulating hormone
Secukinumab
Daratumumab
OMALIZUMAB
Dulaglutide
Trastuzumab emtansine
palivizumab
Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
Eculizumab
LIPOPOLYSACCHARIDE FROM ESCHERICHIA COLI
Ranibizumab
CETUXIMAB
Adalimumab
Trastuzumab
Rituximab
Bevacizumab
Nivolumab
belimumab